Hoey Investments Inc. Has $156,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Hoey Investments Inc. lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 7.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 762 shares of the conglomerate’s stock after selling 59 shares during the period. Hoey Investments Inc.’s holdings in Danaher were worth $156,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at approximately $27,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the 4th quarter valued at approximately $31,000. Rialto Wealth Management LLC acquired a new position in Danaher in the 4th quarter valued at approximately $34,000. Hurley Capital LLC acquired a new position in Danaher in the 4th quarter valued at approximately $34,000. Finally, Ameriflex Group Inc. acquired a new position in Danaher in the 4th quarter valued at approximately $38,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Danaher Stock Down 2.2%

NYSE DHR opened at $200.51 on Friday. The firm has a market cap of $143.50 billion, a PE ratio of 37.98, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock’s 50 day simple moving average is $192.80 and its 200 day simple moving average is $211.19. Danaher Co. has a one year low of $171.00 and a one year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. As a group, sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.64%. Danaher’s payout ratio is 24.85%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent research reports. Robert W. Baird dropped their target price on Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Guggenheim reissued a “buy” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Monday, June 9th. Deutsche Bank Aktiengesellschaft dropped their target price on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Leerink Partners increased their target price on Danaher from $225.00 to $230.00 and gave the stock an “outperform” rating in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $248.17.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.